The synergistic effects of DNA-damaging drugs cisplatin and etoposide with a histone deacetylase inhibitor valproate in high-risk neuroblastoma cells

By Groh Tomas   Hrabeta Jan   Khalil Mohammed Ashraf   Doktorova Helena   Eckschlager Tomas   Stiborova Marie  

International Journal of Oncology, Vol. 47, Iss. 1, 2015-07 ,pp. : 343-352

Spandidos Publications

Access to resources Recommend Favorite

Insights into Apoptosis Mechanisms Induced by DNA-Damaging Agents in Burkitt's Lymphoma Cells

By Simoes Magluta Eliane   da Cunha Vasconcelos Flavia   Maia Raquel Ciuvalschi   Klumb Claudete Esteves  

Cancer Investigation, Vol. 27, Iss. 8, 2009-10 ,pp. : 830-835

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of apoptotic signaling pathways in cancer cells as a mechanism of chemotherapy resistance

By Haq R.   Zanke B.  

Cancer and Metastasis Reviews, Vol. 17, Iss. 2, 1998-06 ,pp. : 233-239

Springer Publishing Company

Access to resources Recommend Favorite

Enhancement of Antitumour Activity of Cisplatin by N,N-Diethyl-2-[4-(Phenylmethyl)Phenoxy] Ethanamine.HCl in Human Ovarian Cancer Cells with Intrinsic or Acquired Resistance to Cisplatin

By Kudoh K.   Kikuchi Y.   Hiramatsu H.   Hirata J.   Yamamoto K.   Kita T.   Nagata I.  

European Journal of Cancer, Vol. 33, Iss. 1, 1997-01 ,pp. : 122-128

Elsevier

Access to resources Recommend Favorite

Time-Dependent Changes in Factors Involved in the Apoptotic Process in Human Ovarian Cancer Cells as a Response to Cisplatin

By Kolfschoten G.M.   Hulscher T.M.   Schrier S.M.   van Houten V.M.M.   Pinedo H.M.   Boven E.  

Gynecologic Oncology, Vol. 84, Iss. 3, 2002-03 ,pp. : 404-412

Elsevier

Access to resources Recommend Favorite